Catecholamines (CA)

Catecholamines are a primary class of monoamine signaling molecules comprising dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) [1, 6]. These molecules are synthesized from the amino acid tyrosine and serve as essential neurotransmitters within the central nervous system and as hormones released by the adrenal medulla [1, 11]. They regulate a diverse array of physiological processes, including the sympathetic 'fight-or-flight' response, cardiovascular hemodynamics, motor coordination, and mood [3, 5, 7]. Catecholamines exert their biological effects by binding to and activating specific G protein-coupled receptors (GPCRs), specifically adrenergic receptors (alpha and beta subtypes) and dopamine receptors (D1 through D5) [1, 9]. Clinically, dysregulation of catecholamine production or signaling is a hallmark of numerous disorders, including Parkinson's disease, heart failure, hypertension, and neuroendocrine tumors such as pheochromocytoma [1, 12, 14]. A wide range of pharmacological agents interact with the catecholamine system, including receptor agonists and antagonists, reuptake inhibitors, and inhibitors of metabolic enzymes such as monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) [1, 12, 18].

Other names

MonoaminesPyrocatechols3,4-dihydroxyphenethylaminesAminoethylcatecholsDopamineNorepinephrineEpinephrine

Pharmacological agents modulate the catecholamine system through several mechanisms: direct agonism or antagonism of adrenergic and dopaminergic receptors, inhibition of neurotransmitter reuptake via transporters (NET and DAT), inhibition of metabolic degradation (MAO and COMT inhibitors), prevention of vesicular storage (VMAT inhibitors), or provision of biosynthetic precursors to increase endogenous levels [1, 2, 4, 12].